Turner Syndrome: Genotype and Phenotype
Launched by EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD) · Oct 4, 2000
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Turner syndrome (TS) is a sporadic disorder affecting \~ 1/2500 live female births. It is caused by the absence of all or significant parts of one sex-chromosome. Major developmental consequences include severe short stature, ovarian failure and distinctive cognitive and behavioral traits, with renal and cardiovascular defects affecting a minority. Adults with TS have excessive rates of osteoporosis, hypertension and diabetes mellitus and experience morbidity and mortality several-fold higher than the general population. Many of the problems of TS result from haplo-insufficiency for X-chrom...
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA - for TS Subjects:
- • Phenotypic females greater than or equal to 10 years of age
- • Evidence of X-chromosomal abnormality
- • Those with a karyotype of 45X/46XX must have at least 80% 45X lymphocytes.
- EXCLUSION CRITERIA - for TS Subjects:
- • Co-existing autosomal defects
- • Pregnancy
- INCLUSION CRITERIA - for the Parents of TS Subjects (for DNA only):
- • Biological parent of a TS subject
- • Willingness to participate
- EXCLUSION CRITERIA - for the Parents of TS Subjects (for DNA only):
- • None
About Eunice Kennedy Shriver National Institute Of Child Health And Human Development (Nichd)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is a prominent research agency within the National Institutes of Health (NIH), dedicated to advancing the health and well-being of children, families, and individuals across the lifespan. NICHD supports a wide range of clinical trials and research initiatives aimed at understanding the complex biological, behavioral, and environmental factors that influence human development and health. By fostering innovative research and facilitating collaboration among scientists, healthcare professionals, and communities, NICHD plays a vital role in translating scientific discoveries into effective interventions and policies that enhance child health, reproductive health, and the prevention of diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
Carolyn A Bondy, M.D.
Principal Investigator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials